P. Wijngaard

1.1k total citations
26 papers, 943 citations indexed

About

P. Wijngaard is a scholar working on Surgery, Immunology and Computational Theory and Mathematics. According to data from OpenAlex, P. Wijngaard has authored 26 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Immunology and 5 papers in Computational Theory and Mathematics. Recurrent topics in P. Wijngaard's work include Lipoproteins and Cardiovascular Health (12 papers), Computational Drug Discovery Methods (5 papers) and Transplantation: Methods and Outcomes (4 papers). P. Wijngaard is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Computational Drug Discovery Methods (5 papers) and Transplantation: Methods and Outcomes (4 papers). P. Wijngaard collaborates with scholars based in Netherlands, United States and United Kingdom. P. Wijngaard's co-authors include Hans Clevers, M J Metzelaar, H K Nieuwenhuis, J J Sixma, Peter J. Peters, N D MacHugh, Paul Mohaçsi, W. Ivan Morrison, David Kallend and William C. Davis and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

P. Wijngaard

24 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Wijngaard Netherlands	11	387	264	207	147	87	26	943
Márton Keszei United States	18	603 1.6×	260 1.0×	92 0.4×	77 0.5×	79 0.9×	36	1.1k
Michael F. Concino United States	15	781 2.0×	500 1.9×	196 0.9×	100 0.7×	109 1.3×	21	1.5k
Kirsty Moore United Kingdom	9	299 0.8×	273 1.0×	101 0.5×	371 2.5×	137 1.6×	25	1.2k
Janet L. Wee Australia	18	303 0.8×	150 0.6×	111 0.5×	270 1.8×	75 0.9×	26	756
Angela Holder United Kingdom	16	171 0.4×	361 1.4×	174 0.8×	37 0.3×	41 0.5×	35	919
Douglas J. Dorahy Australia	17	173 0.4×	325 1.2×	69 0.3×	224 1.5×	124 1.4×	21	911
Anand M. Gautam Australia	19	899 2.3×	351 1.3×	62 0.3×	92 0.6×	99 1.1×	39	1.3k
Anthony Secreto United States	9	415 1.1×	697 2.6×	99 0.5×	130 0.9×	251 2.9×	15	1.4k
Yasuhiro Nakayama Japan	19	276 0.7×	382 1.4×	80 0.4×	45 0.3×	73 0.8×	60	1.0k
Till A. Röhn Switzerland	14	549 1.4×	271 1.0×	45 0.2×	66 0.4×	22 0.3×	20	860

Countries citing papers authored by P. Wijngaard

Since Specialization

Citations

This map shows the geographic impact of P. Wijngaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Wijngaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Wijngaard more than expected).

Fields of papers citing papers by P. Wijngaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Wijngaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Wijngaard. The network helps show where P. Wijngaard may publish in the future.

Co-authorship network of co-authors of P. Wijngaard

This figure shows the co-authorship network connecting the top 25 collaborators of P. Wijngaard. A scholar is included among the top collaborators of P. Wijngaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Wijngaard. P. Wijngaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Psaltis, Peter J., Scott M. Wright, Frederick J. Raal, et al.. (2023). Inter-Individual Variability in LDL-C Reductions With Inclisiran—Pooled Data From ORION-10 and ORION-11. Heart Lung and Circulation. 32. S291–S291. 1 indexed citations

Colquhoun, David, R. Scott Wright, Kausik K. Ray, et al.. (2023). Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11). Heart Lung and Circulation. 32. S387–S387. 1 indexed citations

McQuillan, B., R. Scott Wright, David Kallend, et al.. (2023). Pooled Safety and Efficacy of Inclisiran in Patients With Statin Intolerance (ORION-10 and ORION-11). Heart Lung and Circulation. 32. S299–S299.

Wijngaard, P., et al.. (2023). From network analysis to experimental validation: identification of regulators of non-muscle myosin II contractility using the folded-gastrulation signaling pathway. BMC Molecular and Cell Biology. 24(1). 32–32.

Landmesser, Ulf, Arash Haghikia, LA Leiter, et al.. (2020). Effect of inclisiran, the siRNA against PCSK9, on platelets, immune cells and immunological biomarkers - a pre-specified analysis from ORION-1.. Cardiovascular Research. 16 indexed citations

Wright, R. Scott, David Kallend, Frederick J. Raal, et al.. (2020). Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11). European Heart Journal. 41(Supplement_2). 3 indexed citations

Raal, Frederick J., Norman E. Lepor, David Kallend, et al.. (2019). Inclisiran Durably Lowers Ldl-C And Pcsk9 Expression In Subjects With Homozygous Familial Hypercholesterolaemia: The Orion-2 Pilot Study. Atherosclerosis. 287. e7–e7. 9 indexed citations

Ray, Kausik K., Robert M. Stoekenbroek, David Kallend, et al.. (2018). Effect of an RNAi therapeutic targeting PCSK9 on atherogenic lipoproteins: Pre-specified secondary endpoints in orion 1. Atherosclerosis. 275. e9–e9. 2 indexed citations

Reijers, Joannes A. A., David Kallend, Karen E. Malone, et al.. (2017). MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216. Cardiovascular Drugs and Therapy. 31(4). 381–389. 41 indexed citations

10.

Kallend, David, Joannes A. A. Reijers, S. Eralp Bellibas, et al.. (2015). A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease. European Heart Journal - Cardiovascular Pharmacotherapy. 2(1). 23–29. 62 indexed citations

11.

Mohaçsi, Paul, et al.. (1997). Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.. PubMed. 16(5). 484–92. 117 indexed citations

12.

Toye, Philip, M J Metzelaar, P. Wijngaard, et al.. (1995). Characterization of the gene encoding the polymorphic immunodominant molecule, a neutralizing antigen of Theileria parva. The Journal of Immunology. 155(3). 1370–1381. 35 indexed citations

13.

Wijngaard, P., Heleen Doornewaard, Andrea E. van der Meulen‐de Jong, et al.. (1995). Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.. PubMed. 13(5). 869–75. 6 indexed citations

14.

Wijngaard, P., Andrea E. van der Meulen‐de Jong, Frits H.J. Gmelig Meyling, Nicolaas de Jonge, & Henk‐Jan Schuurman. (1994). Soluble CD8 and CD25 in serum of patients after heart transplantation. Clinical & Experimental Immunology. 97(3). 505–509. 7 indexed citations

15.

MacHugh, N D, P. Wijngaard, Hans Clevers, & William C. Davis. (1993). 6.13 Clustering of monoclonal antibodies recognizing different members of the WC1 gene family. Veterinary Immunology and Immunopathology. 39(1-3). 155–160. 28 indexed citations

16.

Wijngaard, P., et al.. (1992). Presence of CD 16 on Endothelial Cells in Heart Transplant Rejection: an Immunohistochemical Study. Scandinavian Journal of Immunology. 35(5). 569–573. 6 indexed citations

17.

Wijngaard, P., M J Metzelaar, N D MacHugh, W. Ivan Morrison, & Hans Clevers. (1992). Molecular characterization of the WC1 antigen expressed specifically on bovine CD4-CD8- gamma delta T lymphocytes. The Journal of Immunology. 149(10). 3273–3277. 123 indexed citations

18.

Horst, E, et al.. (1991). A method for cDNA cloning in COS cells irrespective of subcellular site of expression. Nucleic Acids Research. 19(16). 4556–4556. 16 indexed citations

19.

Metzelaar, M J, P. Wijngaard, Peter J. Peters, et al.. (1991). CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells.. Journal of Biological Chemistry. 266(5). 3239–3245. 334 indexed citations

20.

Wijngaard, P., J. A. Gimpel, Henk‐Jan Schuurman, et al.. (1990). Monitoring rejection after heart transplantation: cytoimmunological monitoring on blood cells and quantitative birefringence measurements on endomyocardial biopsy specimens.. Journal of Clinical Pathology. 43(2). 137–142. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact